ICAN | 4 Dec 2023 ICAN can finally announce that FDA now represents that it has produced all documents in the biologic product file of Pfizer’s COVID-19 vaccine for ages 16 and up. With this final batch, the documents, presumably those relied upon by FDA to approve the vaccine, are finally in the hands of the…
MARYANNE DEMASI, PHD | 2 Dec 2023 I, and others, have reported on the exaggerated claims made by vaccine manufacturers about the benefits of the COVID-19 vaccines. In November 2020 for example, Pfizer published results in a press release claiming its mRNA vaccine was “95% effective against COVID-19.” The statistic was widely cited by politicians, academics, and the media.…
PAUL D. THACKER | 30 Nov 2023 Why won’t congressional investigators force the CDC Director to explain why Pfizer and Moderna’s PR firm is embedded at the agency’s vaccine center? Congressional leaders with the House Energy and Commerce investigative subcommittee will question CDC Director Mandy Cohen tomorrow in what should be an interesting hearing on restoring public…
Suzanne Burdick, Ph.D. | 7 Nov 2023 Two U.S. Food and Drug Administration (FDA) officials involved in the agency’s decision to license Moderna’s COVID-19 vaccine left the FDA and immediately took jobs with Moderna, according to The BMJ’s new report on the “revolving door” problem between the FDA and Big Pharma. Two U.S. Food and…
Paul D Thacker | 24 Oct 2023 Guest essay by Kim Witczak, globally renowned advocate for pharmaceutical drug safety and FDA reform. Hello readers, today’s essay comes from Kim Witczak, who serves as a consumer representative to a Food and Drug Administration (FDA) advisory committee, and has spent the last two decades advocating for better…
Igor Chudov | 16 Oct 2023 Pfizer’s Greed and Recklessness Will Catch Up with Them. That Happened to Purdue Pharma SUMMARY: The stock market may be waking up to the possibility that Pfizer may go bankrupt due to the upcoming Covid vaccine claims. Many parallels can be drawn between the corporate behaviors of Pfizer and Purdue…
CNBC | 11 April 2018 Goldman Sachs analysts attempted to address a touchy subject for biotech companies, especially those involved in the pioneering “gene therapy” treatment: cures could be bad for business in the long run. “Is curing patients a sustainable business model?” analysts ask in an April 10 report entitled “The Genome Revolution.” “The…
Trust the Evidence | 12 Oct 2023 Commercial influences and deceit leading to the poisoning of children You’ve probably all tried a cough syrup at some point; you may have given it to your children, but recently, global contamination has proven fatal. Cough syrup produced by one manufacturer, Digital Vision Pharma, has killed dozens of children in…
Juliet Bonnay | 6 Sep 2023 Eli Lilly told Attorney General Ramsey Clark to get Bobby to back off re-opening the investigation into his brother’s assassination. Or else… The only thing in the world that can bring the country back to sanity is bringing out the truth – the whole Truth and nothing but the…
Maryanne Demasi | 14 Aug 2023 The latest admission by the FDA commissioner has renewed concerns that the agency lacks independence and that it cannot be trusted. In a recent interview, FDA commissioner Robert Califf admitted to helping Pfizer promote its antiviral drug ‘Paxlovid.’ “I felt that I had an obligation as a public health…